Skip to content
LaunchIndex
Browse/2026/08/tempomeds.com

tempo meds — clinician-led GLP-1, NAD+ and peptide care

tempomeds.com

LaunchIndex first observed tempo meds — clinician-led GLP-1, NAD+ and peptide care (tempomeds.com) live on 18 August 2026. View its launch screenshot, category, and verification evidence.

Screenshot of tempomeds.com
Captured August 18, 2026 13:32 as part of the recorded launch evidence.
Observed launch story

A launch record built from evidence.

tempo meds — clinician-led GLP-1, NAD+ and peptide care (tempomeds.com) was first observed live on 18 August 2026.

Tempo Meds provides clinician-led telehealth care for weight management, energy, recovery, and skin with prescription-based treatments and home delivery.

Its profile is classified as Professional service within Health / Health and wellness.

Recorded evidence

What the launch signal contained.

First observed live
Previous state
No prior non-live observation
Last verified
Canonical host
tempomeds.com
Category
Health / Health and wellness
Website type
Professional service
Observed title
tempo meds — clinician-led GLP-1, NAD+ and peptide care
Observed description
Weight, energy, recovery and skin — real prescriptions from licensed US clinicians, shipped free to your door and adjusted every 90 days.
Detected technologies
None detected
Screenshot captured
Evidence source
Browser observation · Local
Evidence confidence
93%
HTTP status
200
Website owner

Is this your website?

Claim this profile to add verified owner information.

Claim website
Community signal

What do you make of this launch?

Vote on the site and leave a short note for other people exploring the new web.

↑0Up
↓0Down

Join the discussion

Sign in with Google to vote or comment.

Sign in to participate

Comments

0 comments
No comments yet

Be the first to leave a useful observation.

Report an issueFlag spam, illegal or harmful content, or inaccurate information.

Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.

Private to moderators · 10–2,000 characters